The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.
Source link
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
Date:
More like thisRelated
Bayer Swings to Net Profit on Smaller Litigation Charges
The company said its 2026 sales and earnings forecasts...
Jury selection begins for trial against former New Mexico lawmaker accused of corruption
ALBUQUERQUE, N.M. (KRQE) – Five years after accusations of...